ORINASE-MET 2.0 GLIMEPRIDE 2MG/METFOMIN 500MG TABS

Orinase-Met is a combination medication that contains Glimepiride (2 mg) and Metformin (500 mg). It is primarily used in the management of type 2 diabetes mellitus. Glimepiride is a sulfonylurea that helps lower blood sugar levels by stimulating the pancreas to release more insulin. Metformin, on the other hand, is a biguanide that improves insulin sensitivity and decreases glucose production in the liver.

Together, these two active ingredients work synergistically to control blood sugar levels effectively, making Orinase-Met a popular choice for patients who require dual therapy for diabetes management. It is particularly beneficial for individuals who struggle to maintain their blood glucose levels with diet and exercise alone. In Kenya, Orinase-Met is prescribed to help prevent complications associated with diabetes, such as cardiovascular disease and neuropathy, while promoting better overall glycemic control.